InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
2
T+90 hit rate
33%
T+90 mean return
+0.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by SKARVAN KATHLEEN, Chairman & CEO. Director active across 2 companies, notably Electromed, Inc.. Cumulatively, 19 reports have been logged. Breakdown: 5 buys · 2 sells. Total volume traded: €1.3m. History available since 14 May 2021. The latest transaction was disclosed on 14 February 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations19 total
40,000 shares@ US$1.804.8% of flowCommon StockSEC:0001437749-25-004433:0
3,000 shares0Common StockSEC:0001437749-24-036598:0
42,453 shares@ US$28.164179.3% of flowCommon StockSEC:0001437749-24-035878:0
1,893 shares@ US$11.8829.1% of flowCommon Stock, par value $0.01 per shareSEC:0001367859-24-000028:0
3,000 shares0Common StockSEC:0001437749-23-033692:0
1,107 shares@ US$10.83250.8% of flowCommon StockSEC:0001437749-23-020139:0
300 shares@ US$8.803.5% of flowCommon Stock, par value $.01 per shareSEC:0001367859-23-000116:0
Ideal exit: 8 Mar 2024 (T+270)
15,000 shares@ US$1.311.3% of flowCommon StockSEC:0001437749-23-005530:0
1,699 shares@ US$12.3627.4% of flowCommon Stock, par value $0.01 per shareSEC:0001367859-23-000053:0
20,000 shares@ US$1.752.4% of flowCommon StockSEC:0001437749-22-022443:0
14,400 shares0Common StockSEC:0001437749-22-016762:0
1,142 shares@ US$14.000.0083% mcap50.0% of flowCommon Stock, par value $0.01 per shareSEC:0001367859-22-000038:0
1,142 shares@ US$14.000.0083% mcap100.0% of flowCommon Stock, par value $0.01 per shareSEC:0001367859-22-000038
10,900 shares0Common StockSEC:0001437749-21-016493:0
10,900 shares0Common StockSEC:0001437749-21-016493
5,000 shares@ US$9.8725.0% of flowCommon StockSEC:0001437749-21-012687
Ideal exit: 8 Feb 2022 (T+270)
5,000 shares@ US$9.8725.0% of flowCommon StockSEC:0001437749-21-012686
Ideal exit: 8 Feb 2022 (T+270)
5,000 shares@ US$9.870.022% mcap25.0% of flowCommon StockSEC:0001437749-21-012687:0
Ideal exit: 8 Feb 2022 (T+270)
5,000 shares@ US$9.870.022% mcap25.0% of flowCommon StockSEC:0001437749-21-012686:0
Ideal exit: 8 Feb 2022 (T+270)
19 of 19 declarations
About SKARVAN KATHLEEN
Kathleen Skarvan is the President & CEO of Electromed, Inc. and Citizens Community Bancorp Inc. She leads strategic operations and oversees the implementation of the company's objectives. With a strong background in the healthcare sector, Kathleen is responsible for innovation and revenue growth.
